Cited by 918Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerTGF-β signaling in diseases

p14ARF links the tumour suppressors RB and p53

Bates, Stewart, Phillips, Andrew C., Clark, Paula A., Stott, Francesca, Peters, Gordon, Ludwig, Robert L., Vousden, Karen H.·1998·Nature

Integrity signals

Registry

Crossref · 10.1038/25867

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • E2F1 can induce ARF, which blocks MDM2-mediated p53 degradation, and it can also induce SIRT1, which impairs p53 function through deacetylation.

    “E2F1 can induce ARF, which blocks MDM2-mediated p53 degradation,226 and it can also induce SIRT1, which impairs p53 function through deacetylation.227”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [226]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H.
Affiliations
Frederick National Laboratory for Cancer Research (US)
Venue
Nature
Published
1998-09
Volume
395
Issue
6698
Pages
124-125
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1804201762
Cited by
918
References
1
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 12 · 2022: 2 · 2021: 13 · 2020: 16 · 2019: 14 · 2018: 14 · 2017: 13 · 2016: 9 · 2015: 17 · 2014: 17 · 2013: 34 · 2012: 25
FWCI
34.32
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
p14ARF, p19ARF, retinoblastoma protein, p53, E2F1, MDM2, tumor suppression, cell proliferation, cell cycle, transcriptional activation, p53 degradation
MeSH terms
Carrier Proteins, Cell Cycle, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Models, Biological, Mutation, Proteins, Transcription Factors, Tumor Cells, Cultured, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, Tumor Suppressor Protein p14ARF, Transcription Factor DP1, E2F Transcription Factors, Retinoblastoma-Binding Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review